No, I think that it would be smarter for them to partner with BP for a single, high profile indication and keep the rest for themselves. This would give them credibility in the market, with doctors, and provide the capital they need to finish the job on other indications. We are talking about, arguably, a cure for the most prevalent, most diverse disease of all of man and animal...with minimal side effects...NWBO is currently the frontrunner to supply a drug to "cure" all inoperable and operable solid tumors...there is plenty of pie to go around. JMHO